Razvan Lapadat

4.8k total citations · 1 hit paper
22 papers, 4.1k citations indexed

About

Razvan Lapadat is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Razvan Lapadat has authored 22 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Razvan Lapadat's work include Lung Cancer Treatments and Mutations (3 papers), Gene expression and cancer classification (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Razvan Lapadat is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Gene expression and cancer classification (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Razvan Lapadat collaborates with scholars based in United States, United Kingdom and Canada. Razvan Lapadat's co-authors include Gary L. Johnson, Paul A. Bunn, Wilbur A. Franklin, Michio Sugita, Mark W. Geraci, Fred R. Hirsch, Samir E. Witta, Christopher D. Coldren, Bifeng Gao and Roy M. Bremnes and has published in prestigious journals such as Science, Journal of Clinical Oncology and Journal of Cellular Physiology.

In The Last Decade

Razvan Lapadat

21 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases

2002 3.6k citations Gary L. Johnson, Razvan Lapadat Science profile →

Peers

Countries citing papers authored by Razvan Lapadat

Since Specialization

Citations

This map shows the geographic impact of Razvan Lapadat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Razvan Lapadat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Razvan Lapadat more than expected).

Fields of papers citing papers by Razvan Lapadat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Razvan Lapadat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Razvan Lapadat. The network helps show where Razvan Lapadat may publish in the future.

Co-authorship network of co-authors of Razvan Lapadat

This figure shows the co-authorship network connecting the top 25 collaborators of Razvan Lapadat. A scholar is included among the top collaborators of Razvan Lapadat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Razvan Lapadat. Razvan Lapadat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Telecytology validation: is there a recipe for everybody? 2022 ·Journal of the American Society of Cytopathology ·(unknown), (unknown), Patrick J. McIntire, (unknown), Razvan Lapadat, (unknown), Stefan E. Pambuccian, Eva M. Wojcik, Swati Mehrotra, Güliz A. Barkan	6
2	A pair of S‐silencing single nucleotide variants cis‐linked on GYPB 2021 ·Transfusion ·Razvan Lapadat, Waseem Q. Anani, (unknown), (unknown), Sunitha Vege, Christine Lomas‐Francis, Connie M. Westhoff, (unknown), Gregory A. Denomme	1
3	Accuracy of Subclassification and Grading of Renal Tumors on Fine Needle Aspiration Cytology Alone 2021 ·Acta Cytologica ·Heather Chen, Razvan Lapadat, Ricardo R. Lastra, Anna Biernacka, (unknown), Jeffrey Mueller, Stefan E. Pambuccian, Güliz A. Barkan, Eva M. Wojcik, Tatjana Antic	2
4	Current state of Grand Rounds in U.S. pathology training programs 2020 ·Annals of Diagnostic Pathology ·(unknown), Recep Niğdelioğlu, Razvan Lapadat, Vijayalakshmi Ananthanarayanan, Güliz A. Barkan, Eva M. Wojcik, Stefan E. Pambuccian	0
5	The utilization and utility of immunostains in body fluid cytology 2020 ·Cancer Cytopathology ·(unknown), Razvan Lapadat, (unknown), Swati Mehrotra, Güliz A. Barkan, Eva M. Wojcik, Stefan E. Pambuccian	7
6	Clonal highlights: Clonal seborrheic keratoses often demonstrates p16 expression 2019 ·Journal of Cutaneous Pathology ·(unknown), Jodi Speiser, (unknown), Razvan Lapadat, Kumaran Mudaliar	2
7	“Teardrop,” “comet,” and “bowling‐pin” cells in a hobnail variant of papillary thyroid carcinoma fine needle aspirate 2019 ·Diagnostic Cytopathology ·Swati Mehrotra, Razvan Lapadat, Güliz A. Barkan, Stefan E. Pambuccian	5
8	Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls 2018 ·Acta Neuropathologica Communications ·(unknown), (unknown), Maria N. Garnovskaya, (unknown), (unknown), Sunil J. Patel, (unknown), Malak Abedalthagafi, Craig Horbinski, Mary S. Richardson, Daynna J. Wolff, Razvan Lapadat, William Moore, Fausto J. Rodríguez, (unknown), Adriana Olar	5
9	Gamna–Gandy bodies in papillary renal cell carcinoma 2017 ·Diagnostic Cytopathology ·Razvan Lapadat, Güliz A. Barkan, (unknown), Stefan E. Pambuccian	2
10	Mulberry cells in the thyroid: warthin–finkeldey‐like cells in hashimoto thyroiditis‐associated lymphoma 2016 ·Diagnostic Cytopathology ·Razvan Lapadat, (unknown), Swati Mehrotra, (unknown), Stefan E. Pambuccian	2
11	Central nervous system involvement by myeloid sarcoma: a report of 12 cases and review of the literature 2016 ·Clinical Neuropathology ·Adriana Olar, Razvan Lapadat, Christian J. Davidson, Thor D. Stein, Sonika Dahiya, Arie Perry, (unknown)	14
12	The PhenoGen Informatics website: tools for analyses of complex traits 2007 ·BMC Genetics ·Sanjiv V. Bhave, (unknown), Tzu Phang, Laura Saba, Razvan Lapadat, Katerina Kechris, (unknown), Daniel McGoldrick, (unknown), Sonia M. Leach, (unknown), Allison A. Ellington, (unknown), (unknown), Jonathan Mangion, John K. Belknap, Robert W. Williams, Lawrence Hunter, Paula L. Hoffman, Boris Tabakoff	34
13	Baseline Gene Expression Predicts Sensitivity to Gefitinib in Non–Small Cell Lung Cancer Cell Lines 2006 ·Molecular Cancer Research ·Christopher D. Coldren, Barbara A. Helfrich, Samir E. Witta, Michio Sugita, Razvan Lapadat, Chan Zeng, (unknown), Wilbur A. Franklin, Fred R. Hirsch, Mark W. Geraci, Paul A. Bunn	107
14	Candidate genes and their regulatory elements: alcohol preference and tolerance 2006 ·Mammalian Genome ·Laura Saba, Sanjiv V. Bhave, Nicholas J. Grahame, Paula J. Bice, Razvan Lapadat, John K. Belknap, Paula L. Hoffman, Boris Tabakoff	52
15	Genes Induced by Reovirus Infection Have a Distinct Modular Cis- Regulatory Architecture 2005 ·Current Genomics ·Razvan Lapadat, Roberta L. DeBiasi, Gary L. Johnson, Kenneth L. Tyler, Imran Shah	1
16	Defining gefitinib sensitivity/resistance in non-small cell lung cancer (NSCLC) cell lines by affymetrix gene arrays 2004 ·Journal of Clinical Oncology ·Fred R. Hirsch, Wilbur A. Franklin, Samir E. Witta, B. Helfrich, Razvan Lapadat, Christopher D. Coldren, Michio Sugita, Paul A. Bunn	5
17	Defining gefitinib sensitivity/resistance in non-small cell lung cancer (NSCLC) cell lines by affymetrix gene arrays 2004 ·Journal of Clinical Oncology ·F. R. Hirsch, Wilbur A. Franklin, Samir E. Witta, B. Helfrich, Razvan Lapadat, Christopher D. Coldren, Michio Sugita, P. A. Bunn	3
18	MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF‐2 in fibroblasts 2003 ·Journal of Cellular Physiology ·Kamala Kesavan, (unknown), Weiyong Sun, Razvan Lapadat, Saiphone Webb, Gary L. Johnson, Timothy Garrington	72
19	Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. 2002 ·PubMed ·Michio Sugita, Mark W. Geraci, Bifeng Gao, Roger Powell, Fred R. Hirsch, Gary L. Johnson, Razvan Lapadat, Edward Gabrielson, Roy M. Bremnes, Paul A. Bunn, Wilbur A. Franklin	106
20	Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases breakdown → 2002 ·Science ·Gary L. Johnson, Razvan Lapadat	3608

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact